Page last updated: 2024-09-03

olmesartan medoxomil and Hypercholesterolemia

olmesartan medoxomil has been researched along with Hypercholesterolemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fan, P; Saku, K; Tanaka, H; Zhang, B	1

Other Studies

1 other study(ies) available for olmesartan medoxomil and Hypercholesterolemia

Article	Year
Angiotensin II type-1 receptor antagonist, CS-866, reduces blood pressure without affecting glucose/insulin metabolism in cholesterol-fed rabbits. British journal of biomedical science, 2001, Volume: 58, Issue:4 Topics: Angiotensin Receptor Antagonists; Animals; Blood Glucose; Blood Pressure; Female; Glucose Tolerance Test; Hypercholesterolemia; Imidazoles; Insulin; Olmesartan Medoxomil; Rabbits; Tetrazoles	2001

Article

Year

Angiotensin II type-1 receptor antagonist, CS-866, reduces blood pressure without affecting glucose/insulin metabolism in cholesterol-fed rabbits.

British journal of biomedical science, 2001, Volume: 58, Issue:4

Topics: Angiotensin Receptor Antagonists; Animals; Blood Glucose; Blood Pressure; Female; Glucose Tolerance Test; Hypercholesterolemia; Imidazoles; Insulin; Olmesartan Medoxomil; Rabbits; Tetrazoles

2001